On Friday, I was cagey about whether there would be a Christmas-week newsletter. I was worried that some resident of Mount Crumpit would be tempted to throw something important into

In theory, this is my last newsletter for the next 10 days. I say “in theory,” because I figure there’s a 50/50 chance of someone dumping news into the void

Quick Brian Reid Scheduling Note: I’ve only missed a couple of J.P. Morgan Healthcare Conferences since 2010 (with the exception of the pandemic years, which we don’t talk about).  But

Thanks to everyone who weighed in on the future of Cost Curve yesterday. I’m keeping the survey open for another day, so if you haven’t clicked over, I’d be appreciative

If you want to search Cost Curve back issues or link to anything you read here, the web links and archive are online at costcurve.beehiiv.com. You can subscribe there, too.

If you want to search Cost Curve back issues or link to anything you read here, the web links and archive are online at costcurve.beehiiv.com. You can subscribe there, too.

Programming Note: No Curve tomorrow unless there’s news [knocks on wood]. Back Monday. Let it snow. If you want to search Cost Curve back issues or link to anything you

If you want to search Cost Curve back issues or link to anything you read here, the web links and archive are online at costcurve.beehiiv.com. You can subscribe there, too.

I really tried to make it a whole newsletter without mentioning 340B. I came close, but — alas — I can’t get away. If you want to search Cost Curve

One of the most important needs in the biopharma industry is communicators who can make the case not only for innovation but also for the broader policy and business environment